These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 30517302)
21. ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma. Schrama D; Scherer D; Schneider M; Zapatka M; Bröcker EB; Schadendorf D; Ugurel S; Kumar R; Becker JC J Invest Dermatol; 2011 Jun; 131(6):1280-90. PubMed ID: 21390047 [TBL] [Abstract][Full Text] [Related]
22. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer. Li YK; Xu Q; Sun LP; Gong YH; Jing JJ; Xing CZ; Yuan Y World J Gastroenterol; 2020 Jan; 26(3):307-323. PubMed ID: 31988591 [TBL] [Abstract][Full Text] [Related]
23. The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer. Liang J; Jiang T; Yao RY; Liu ZM; Lv HY; Qi WW Cancer Chemother Pharmacol; 2010 Aug; 66(3):493-500. PubMed ID: 19960344 [TBL] [Abstract][Full Text] [Related]
24. Study on association between ERCC5 single nucleotide polymorphism and susceptibility to esophageal cancer. Zhang C; Liao Z; Yu G; Huang W; Song X J BUON; 2017; 22(4):979-984. PubMed ID: 28952217 [TBL] [Abstract][Full Text] [Related]
25. Impact of SNP-SNP interactions of DNA repair gene Sang L; Lv Z; Sun LP; Xu Q; Yuan Y World J Gastroenterol; 2018 Feb; 24(5):602-612. PubMed ID: 29434449 [TBL] [Abstract][Full Text] [Related]
26. Association between ERCC5 gene polymorphisms and breast cancer risk. Na N; Dun E; Ren L; Li G Int J Clin Exp Pathol; 2015; 8(3):3192-7. PubMed ID: 26045839 [TBL] [Abstract][Full Text] [Related]
27. Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer. Yang G; Yang Y; Ma X; Huang L; Li W; Song X; Zhang H; Liu W; Lu J Technol Cancer Res Treat; 2020; 19():1533033820943244. PubMed ID: 32812509 [TBL] [Abstract][Full Text] [Related]
28. Association of XPD Asp312Asn polymorphism and response to oxaliplatin-based first-line chemotherapy and survival in patients with metastatic colorectal cancer. Liu Z; Kong J; Kong Y; Cai F; Xu X; Liu J; Wang S Adv Clin Exp Med; 2019 Nov; 28(11):1459-1468. PubMed ID: 31756062 [TBL] [Abstract][Full Text] [Related]
29. Genetic Association between ERCC5 rs17655 Polymorphism and Colorectal Cancer Risk: Evidence Based on a Meta-analysis. Zeng Y; Wei L; Wang YJ; Liu C Asian Pac J Cancer Prev; 2015; 16(13):5565-71. PubMed ID: 26225711 [TBL] [Abstract][Full Text] [Related]
30. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival. Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974 [TBL] [Abstract][Full Text] [Related]
31. Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer. He C; Duan Z; Li P; Xu Q; Yuan Y Anticancer Drugs; 2013 Mar; 24(3):300-5. PubMed ID: 23211354 [TBL] [Abstract][Full Text] [Related]
32. Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck. Ma H; Yu H; Liu Z; Wang LE; Sturgis EM; Wei Q Pharmacogenet Genomics; 2012 Jan; 22(1):50-7. PubMed ID: 22108238 [TBL] [Abstract][Full Text] [Related]
33. Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese. Duan Z; He C; Gong Y; Li P; Xu Q; Sun LP; Wang Z; Xing C; Yuan Y Gene; 2012 Dec; 511(2):274-9. PubMed ID: 22982416 [TBL] [Abstract][Full Text] [Related]
34. Association analysis of ERCC5 gene polymorphisms with risk of breast cancer in Han women of northwest China. Wang H; Wang T; Guo H; Zhu G; Yang S; Hu Q; Du Y; Bai X; Chen X; Su H Breast Cancer; 2016 May; 23(3):479-85. PubMed ID: 25644244 [TBL] [Abstract][Full Text] [Related]
35. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA. Lu B; Li J; Gao Q; Yu W; Yang Q; Li X Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975 [TBL] [Abstract][Full Text] [Related]
36. XPG rs2296147 T>C polymorphism predicted clinical outcome in colorectal cancer. Wang F; Zhang SD; Xu HM; Zhu JH; Hua RX; Xue WQ; Li XZ; Wang TM; He J; Jia WH Oncotarget; 2016 Mar; 7(10):11724-32. PubMed ID: 26887052 [TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer. Lv H; Li Q; Qiu W; Xiang J; Wei H; Liang H; Sui A; Liang J Pathol Oncol Res; 2012 Oct; 18(4):1009-14. PubMed ID: 22549274 [TBL] [Abstract][Full Text] [Related]
38. [The influence of XRCC1 gene polymorphism on the prognosis and safety of stage Ⅲ patients with colorectal cancer who received oxaliplatin based adjuvant chemotherapy]. Li RX; Shang JH; Sun JF Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(11):759-765. PubMed ID: 33765714 [No Abstract] [Full Text] [Related]
39. ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer. Viguier J; Boige V; Miquel C; Pocard M; Giraudeau B; Sabourin JC; Ducreux M; Sarasin A; Praz F Clin Cancer Res; 2005 Sep; 11(17):6212-7. PubMed ID: 16144923 [TBL] [Abstract][Full Text] [Related]
40. Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. Hussain SK; Mu LN; Cai L; Chang SC; Park SL; Oh SS; Wang Y; Goldstein BY; Ding BG; Jiang Q; Rao J; You NC; Yu SZ; Papp JC; Zhao JK; Wang H; Zhang ZF Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2304-9. PubMed ID: 19661089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]